Welcome to our dedicated page for Ouster SEC filings (Ticker: OUST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ouster, Inc. (OUST) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ouster is a public company whose common stock is registered under Section 12(b) of the Exchange Act and listed on the Nasdaq Global Select Market under the symbol OUST, with certain warrants also listed on Nasdaq under other symbols. Its filings offer detailed information on financial performance, governance, and securities.
Ouster submits current reports on Form 8-K to announce material events such as quarterly and year-to-date financial results and the outcomes of its Annual Meeting of Stockholders. These 8-K filings typically reference press releases that include revenue, gross profit, gross margin, operating expenses, net loss, and non-GAAP measures like Non-GAAP Gross Margin and Adjusted EBITDA, as well as voting results on director elections, auditor ratification, advisory votes on executive compensation, and proposed charter amendments.
Investors can also review annual and quarterly reports on Forms 10-K and 10-Q, which Ouster references in its forward-looking statement disclosures. These documents provide broader context on the company’s business, risk factors, and financial statements, complementing the summarized information in earnings press releases.
The filings page may include exchange-related forms such as Form 25, which in Ouster’s case has been used to document the removal of a class of warrants from listing on the Nasdaq Stock Market. This type of filing helps clarify the status of specific securities separate from the common stock.
On Stock Titan, Ouster’s SEC filings are paired with AI-powered summaries that explain key points in plain language, helping users quickly understand complex sections of 10-Ks, 10-Qs, 8-Ks, and other forms. Real-time updates from EDGAR, along with structured access to items like voting results, non-GAAP reconciliations, and listing status information, allow investors to follow OUST’s regulatory history and disclosures efficiently.
Ouster, Inc. (OUST) filed a Form 144 reporting a proposed sale of 40,009 shares of common stock to be executed through E*TRADE on 09/12/2025 on the NASDAQ, with an aggregate market value of $1,140,656.59. The securities were acquired on 09/11/2025 as restricted stock awards under the company's incentive award plan totaling 69,239 shares, and the stated consideration for those awards was services rendered with a payment date noted as 03/28/2024. The filer reports no securities sold in the past three months for the account named. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.
Ouster, Inc. (OUST) filed a Form 144 notice reporting a proposed sale of 26,674 shares of common stock through ETRADE FINANCIAL CORPORATION on 09/12/2025 on the NASDAQ. The filing lists an aggregate market value of $760,475.74 and shows 57,819,244 shares outstanding. The securities to be sold were acquired as restricted stock awards on 09/11/2025, with 46,160 shares noted as the amount of securities acquired, and a payment date of 03/28/2024 described as services rendered. The filer reports "Nothing to Report" for securities sold in the past three months. The notice includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
Ouster, Inc. (OUST) filed a Form 144 notifying the proposed sale of 18,011 shares of its common stock, with an aggregate market value of $513,493.61, expected to be sold on 09/12/2025 on the NASDAQ. The securities were acquired as restricted stock awards and restricted stock units awarded under the company's incentive award plan on various grant dates, with amounts totaling 30,465, 4,500, 225, and 2,083 across the listed grants. The filer previously sold 2,828 shares on 06/12/2025 for gross proceeds of $53,066.29. The filer certifies they are not aware of undisclosed material adverse information about the issuer.
Susan Heystee, a director of Ouster, Inc. (OUST), reported the sale of common stock on 08/13/2025. The Form 4 shows 40,389.6 shares were sold in multiple transactions at a weighted average price of $30.00 (individual trade prices ranged from $30.00 to $30.10). After these dispositions the filing reports 52,264.7 shares beneficially owned by the reporting person. The Form 4 was executed on behalf of Ms. Heystee by an attorney-in-fact and dated 08/15/2025. The filing includes a footnote stating the seller will provide breakdowns of shares sold at each price upon request.
Ouster, Inc. filed a Form 144 disclosing a proposed sale of 40,390 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $1,211,700.00. The filing lists 57,819,244 shares outstanding and gives an approximate sale date of 08/13/2025.
The securities were acquired as restricted stock from the issuer on 04/05/2023. The filer reports no securities sold during the past three months and includes the standard representation that they do not possess undisclosed material adverse information about the issuer.
Ouster reported sequential strength in top-line and gross profit while remaining loss-making. Revenue for the quarter was $35.0 million, up from $27.0 million a year earlier, and six‑month revenue reached $67.7 million versus $52.9 million a year earlier, reflecting stronger product and licensing sales. Gross profit expanded to $15.8 million for the quarter, improving margins as product mix and revenue scale increased.
Despite revenue gains, the company recorded a net loss of $20.6 million for the quarter and $42.6 million for the six months. Operating expenses, particularly general and administrative costs, rose year over year. Liquidity remains a key strength: cash, cash equivalents, restricted cash and short‑term investments totaled about $229.1 million and the company raised approximately $58.5 million net from an at‑the‑market offering in the quarter. The company also recorded legal and IP‑related accruals totaling $11.7 million and disclosed ongoing patent and arbitration matters.
Ouster, Inc. filed an 8-K dated 7 Aug 2025 to disclose Item 2.02, Results of Operations and Financial Condition. The company announced its financial results for the three- and six-month periods ended 30 Jun 2025 and furnished the related press release as Exhibit 99.1. No quantitative figures are included in the filing; investors must refer to the exhibit for details. The filing also lists Item 9.01, providing exhibit indices, and confirms that the information is being furnished, not filed, thereby limiting liability under Section 18 of the Exchange Act. The document reiterates Ouster’s securities listings—common stock (OUST) on Nasdaq Global Select Market and two series of public warrants (OUSTZ, OUSTW). The report was signed by CFO Kenneth P. Gianella.
Because the 8-K contains no financial metrics or forward-looking guidance, the immediate investment impact is likely neutral; material assessment depends on the as-yet-unseen data in Exhibit 99.1.
Director Ernest E Maddock of Ouster (OUST) reported the acquisition of restricted stock units (RSUs) on June 18, 2025. The transaction details include:
- 13,558 RSUs that vest quarterly through June 18, 2026 or the next annual stockholder meeting, contingent on continued service
- 1,500 RSUs that vested immediately on grant date
- Following these transactions, Maddock directly owns 84,177 shares of common stock
Both RSU grants were awarded at $0.00 exercise price. The filing was submitted by Megan Chung as attorney-in-fact on June 20, 2025. This equity compensation grant appears to be part of the company's director compensation program, with a mix of time-based vesting and immediate vesting components.
Director Ted L. Tewksbury III of Ouster received a grant of 13,558 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Tewksbury owns a total of 127,054 shares directly.
Key details of the RSU grant:
- The RSUs will vest in quarterly installments through June 18, 2026, or until the next annual stockholder meeting, whichever comes first
- Each RSU represents the right to receive one share of common stock
- The grant was made at $0 cost to the director
- Vesting is contingent on Tewksbury's continued service with the company
This Form 4 filing was signed by Megan Chung as attorney-in-fact for Tewksbury on June 20, 2025, within the required reporting timeline for insider transactions.
FAQ
What is the current stock price of Ouster (OUST)?
What is the market cap of Ouster (OUST)?
